7 reports

Table ##: Biological Pacemaker - Product Status

  • Cardiac Management
  • Clinical Trial
  • California
  • Switzerland
  • Arizona
  • Michigan
  • Direct Sales
  • Health Provider Density

Table ##: Biological Pacemaker - Product Description

  • Cardiac Management
  • Clinical Trial
  • California
  • United Kingdom
  • Direct Sales
  • Medical Technology Density

Biological Pacemaker

  • Cardiology
  • Clinical Trial
  • Transplantation
  • Hemodialysis Device
  • United States
  • Medical Devices Sales

Table ##: Biological Pacemaker - Product Description

  • Cardiac Management
  • Clinical Trial
  • California
  • Switzerland
  • Los Angeles County
  • Michigan
  • Direct Sales
  • Medical Instrument And Supply Production

The research related to the development of biological pacemakers to treat individuals with slow heartbeats received a grant of $## million from National Institutes of Health (NIH).

  • Cardiac Management
  • APAC
  • EMEA
  • Drug Approval
  • Health Expenditure

Update on October ##: BioHeart, Inc., a developer of stem cell therapies for heart disease, and Airspeed Equity, LLC, a capital management firm, have announced four products: MyoStim Lab Culture Stimulator, Limb Blood Flow Stimulator, Implantable Heart Pacemaker and Biopace Biological Pacemaker.

  • Heart Failure
  • Private Placement
  • Healthcare
  • Drug Development
  • Indiana
  • Dates Price

This BCC Research report focuses on the bone- and joint-related applications of and markets for the various categories of regenerative medicine products currently available and projected to be introduced during the five-year forecast period from 2015 through 2020. Use this report to: - Learn about leading bone and joint...

  • Regenerative Medicine
  • United States
  • Electronic Component Revenue